Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α

FASEB Journal

Volumn 29, Issue 4, 2015, Pages 1591-1602

  Flannigan, Kyle L ^a   Agbor, Terence A ^a   Motta, Jean Paul ^b   Ferraz, José G P ^c   Wang, Rui ^d   Buret, Andre G ^b   Wallace, John L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Gasotransmitter; Healing; Inflammation; Inflammatory bowel disease; Ulcer

Indexed keywords

4 [BIS(2 CHLOROETHYL)OXIDOAMINO]PHENYLALANINE; CYSTATHIONINE GAMMA LYASE; DIALLYL DISULFIDE; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; 2-AMINO-3-(4'-N,N-BIS(2-CHLOROETHYL)AMINO)PHENYLPROPIONIC ACID N-OXIDE; ALLYL COMPOUND; BENZENESULFONIC ACID DERIVATIVE; DINITROBENZENESULFONIC ACID; DISULFIDE; MUSTARD GAS DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLITIS; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY ASSESSMENT; EPITHELIUM CELL; GENE EXPRESSION; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HT 29 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT; WOUND HEALING;

MUS; RATTUS;

ALLYL COMPOUNDS; ANIMALS; BENZENESULFONATES; COLITIS; CYSTATHIONINE GAMMA-LYASE; DISEASE MODELS, ANIMAL; DISULFIDES; GENE EXPRESSION; HT29 CELLS; HUMANS; HYDROGEN SULFIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MUSTARD COMPOUNDS; PHENYLPROPIONATES; PROTEIN STABILITY; RATS; RATS, WISTAR; WOUND HEALING;

EID: 84931478550     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-266015     Document Type: Article

References (60)

1. Abe, K., and Kimura, H. (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16, 1066-1071
2. ATPchannel opener. EMBO J. 20, 6008-6016
3. Zanardo, R. C., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G., and Wallace, J. L. (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 20, 2118-2120
4. Wallace, J. L., Dicay, M., McKnight, W., and Martin, G. R. (2007) Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 21, 4070-4076
5. Wallace, J. L., Vong, L., McKnight, W., Dicay, M., and Martin, G. R. (2009) Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 137, 569-578.e1
6. Calvert, J. W., Coetzee, W. A., and Lefer, D. J. (2010) Novel insights into hydrogen sulfide - mediated cytoprotection. Antioxid. Redox Signal. 12, 1203-1217
7. Szabó, C., and Papapetropoulos, A. (2011) Hydrogen sulphide and angiogenesis: mechanisms and applications. Br. J. Pharmacol. 164, 853-865
8. Wallace, J. L., Ferraz, J. G., and Muscara, M. N. (2012) Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid. Redox Signal. 17, 58-67
9. Flannigan, K. L., McCoy, K. D., and Wallace, J. L. (2011) Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G188-G193
10. Flannigan, K. L., Ferraz, J. G., Wang, R., and Wallace, J. L. (2013) Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism. PLoS One 8, e71962
11. Flannigan, K. L., Agbor, T. A., Blackler, R. W., Kim, J. J., Khan, W. I., Verdu, E. F., Ferraz, J. G., and Wallace, J. L. (2014) Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis. Proc. Natl. Acad. Sci. USA 111, 13559-13564
12. Fiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V., Distrutti, E., Santucci, L., Cirino, G., and Wallace, J. L. (2007) Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 150, 996-1002
13. Mariggiò, M. A., Minunno, V., Riccardi, S., Santacroce, R., De Rinaldis, P., and Fumarulo, R. (1998) Sulfide enhancement of PMN apoptosis. Immunopharmacol. Immunotoxicol. 20, 399-408
14. Pálinkás, Z., Furtmüller, P. G., Nagy, A., Jakopitsch, C., Pirker, K. F., Magierowski, M., Jasnos, K., Wallace, J. L., Obinger, C., and Nagy, P. (2014) Interactions of hydrogen sulfide with myeloperoxidase. [E-pub ahead of print] Br. J. Pharmacol.
15. Dufton, N., Natividad, J., Verdu, E. F., and Wallace, J. L. (2012) Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci. Rep. 2, 499
16. Glover, L. E., and Colgan, S. P. (2011) Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology 140, 1748-1755
17. Colgan, S. P., and Taylor, C. T. (2010) Hypoxia: an alarm signal during intestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 7, 281-287
18. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732
19. Karhausen, J., Furuta, G. T., Tomaszewski, J. E., Johnson, R. S., Colgan, S. P., and Haase, V. H. (2004) Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098-1106
20. Furuta, G. T., Turner, J. R., Taylor, C. T., Hershberg, R. M., Comerford, K., Narravula, S., Podolsky, D. K., and Colgan, S. P. (2001) Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027-1034
21. Keely, S., Glover, L. E., MacManus, C. F., Campbell, E. L., Scully, M. M., Furuta, G. T., and Colgan, S. P. (2009) Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 23, 1338-1346
22. Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., and Colgan, S. P. (2002) Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002
23. Cummins, E. P., Seeballuck, F., Keely, S. J., Mangan, N. E., Callanan, J. J., Fallon, P. G., and Taylor, C. T. (2008) The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156-165
24. Robinson, A., Keely, S., Karhausen, J., Gerich, M. E., Furuta, G. T., and Colgan, S. P. (2008) Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145-155
25. 2S mediates O2 sensing in the carotid body. Proc. Natl. Acad. Sci. USA 107, 10719-10724
26. Lagoutte, E., Mimoun, S., Andriamihaja, M., Chaumontet, C., Blachier, F., and Bouillaud, F. (2010) Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim. Biophys. Acta 1797, 1500-1511
27. Mimoun, S., Andriamihaja, M., Chaumontet, C., Atanasiu, C., Benamouzig, R., Blouin, J. M., Tomé, D., Bouillaud, F., and Blachier, F. (2012) Detoxification of H(2)S by differentiated colonic epithelial cells: implication of the sulfide oxidizing unit and of the cell respiratory capacity. Antioxid. Redox Signal. 17, 1-10
28. Budde, M. W., and Roth, M. B. (2010) Hydrogen sulfide increases hypoxia-inducible factor-1 activity independently of von Hippel-Lindau tumor suppressor-1 in C. elegans. Mol. Biol. Cell 21, 212-217
29. Wallace, J. L., Le, T., Carter, L., Appleyard, C. B., and Beck, P. L. (1995) Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J. Pharmacol. Toxicol. Methods 33, 237-239
30. Wallace, J. L., Blackler, R. W., Chan, M. V., Da Silva, G. J., Elsheikh, W., Flannigan, K. L., Gamaniek, I., Manko, A., Wang, L., Motta, J. P., and Buret, A. G. (2014) Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. [E-pub ahead of print] Antioxid. Redox Signal. doi:10.1089/ars.2014.5901
31. Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., and Wallace, J. L. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795-803
32. Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., and Wallace, J. L. (1996) Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 98, 2076-2085
33. Boughton-Smith, N. K., Wallace, J. L., and Whittle, B. J. (1988) Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25, 115-123
34. Bradley, P. P., Priebat, D. A., Christensen, R. D., and Rothstein, G. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209
35. Lowie, B. J., Wang, X. Y., White, E. J., and Huizinga, J. D. (2011) On the origin of rhythmic calcium transients in the ICC-MP of the mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G835-G845
36. Benavides, G. A., Squadrito, G. L., Mills, R. W., Patel, H. D., Isbell, T. S., Patel, R. P., Darley-Usmar, V. M., Doeller, J. E., and Kraus, D. W. (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. USA 104, 17977-17982
37. Predmore, B. L., Kondo, K., Bhushan, S., Zlatopolsky, M. A., King, A. L., Aragon, J. P., Grinsfelder, D. B., Condit, M. E., and Lefer, D. J. (2012) The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am. J. Physiol. Heart Circ. Physiol. 302, H2410-H2418
38. Wallace, J. L. (2010) Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid. Redox Signal. 12, 1125-1133
39. Koh, M. Y., Spivak-Kroizman, T., Venturini, S., Welsh, S., Williams, R. R., Kirkpatrick, D. L., and Powis, G. (2008) Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 7, 90-100
40. Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., and Powis, G. (2004) Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 3, 233-244
41. Chávez-Piña, A. E., Vong, L., McKnight, W., Dicay, M., Zanardo, R. C., Ortiz, M. I., Castañeda-Hernández, G., and Wallace, J. L. (2008) Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br. J. Pharmacol. 155, 857-864
42. Stipanuk, M. H., and Beck, P. W. (1982) Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 206, 267-277
43. Curtis, V. F., Ehrentraut, S. F., Campbell, E. L., Glover, L. E., Bayless, A., Kelly, C. J., Kominsky, D. J., and Colgan, S. P. (2014) Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. [E-pub ahead of print] FASEB J. doi:10.1096/fj.14-259663
44. Campbell, E. L., Bruyninckx, W. J., Kelly, C. J., Glover, L. E., McNamee, E. N., Bowers, B. E., Bayless, A. J., Scully, M., Saeedi, B. J., Golden-Mason, L., Ehrentraut, S. F., Curtis, V. F., Burgess, A., Garvey, J. F., Sorensen, A., Nemenoff, R., Jedlicka, P., Taylor, C. T., Kominsky, D. J., and Colgan, S. P. (2014) Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66-77
45. Motta, J. P., Flannigan, K. L., Agbor, T. A., Beatty, J. K., Blackler, R. W., Workentine, M. L., Da Silva, G. J., Wang, R., Buret, A. G., and Wallace, J. L. (2014) Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflammatory Bowel Diseases, In press
46. Kaidi, A., Qualtrough, D., Williams, A. C., and Paraskeva, C. (2006) Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66, 6683-6691
47. Wallace, J. L., and Devchand, P. R. (2005) Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br. J. Pharmacol. 145, 275-282
48. Cai, Z., Luo, W., Zhan, H., and Semenza, G. L. (2013) Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc. Natl. Acad. Sci. USA 110, 17462-17467
49. Wright, N. A., Poulsom, R., Stamp, G., Van Norden, S., Sarraf, C., Elia, G., Ahnen, D., Jeffery, R., Longcroft, J., and Pike, C. (1993) Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104, 12-20
50. Mashimo, H., Wu, D. C., Podolsky, D. K., and Fishman, M. C. (1996) Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274, 262-265
51. Taupin, D. R., Kinoshita, K., and Podolsky, D. K. (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc. Natl. Acad. Sci. USA 97, 799-804
52. Louis, N. A., Hamilton, K. E., Kong, T., and Colgan, S. P. (2005) HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. FASEB J. 19, 950-959
53. Bynoe, M. S., Waickman, A. T., Mahamed, D. A., Mueller, C., Mills, J. H., and Czopik, A. (2012) CD73 is critical for the resolution of murine colonic inflammation. J. Biomed. Biotechnol. 2012, 260983
54. Lin, F., Spencer, D., Hatala, D. A., Levine, A. D., and Medof, M. E. (2004) Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J. Immunol. 172, 3836-3841
55. Ajuebor, M. N., Singh, A., and Wallace, J. L. (2000) Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G238-G244
56. 2S) metabolism in mitochondria and its regulatory role in energy production. Proc. Natl. Acad. Sci. USA 109, 2943-2948
57. Jacoby, J. J., Erez, B., Korshunova, M. V., Williams, R. R., Furutani, K., Takahashi, O., Kirkpatrick, L., Lippman, S. M., Powis, G., O'Reilly, M. S., and Herbst, R. S. (2010) Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J. Thorac. Oncol. 5, 940-949
58. Louis, N. A., Robinson, A. M., MacManus, C. F., Karhausen, J., Scully, M., and Colgan, S. P. (2008) Control of IFN-alphaA by CD73: implications for mucosal inflammation. J. Immunol. 180, 4246-4255
59. Mathai, J. C., Missner, A., Kügler, P., Saparov, S. M., Zeidel, M. L., Lee, J. K., and Pohl, P. (2009) No facilitator required for membrane transport of hydrogen sulfide. Proc. Natl. Acad. Sci. USA 106, 16633-16638
60. 2S signals through protein S-sulfhydration. Sci. Signal. 2, ra72